ArticleRSC advances2026
Mild-condition green synthesis of manganese nanoparticles for next-generation broad-spectrum antibacterial applications.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Environmentally benign fabrication of metal nanoparticles has gained considerable attention as a substitute for traditional physical and chemical synthesis methods due to its operational simplicity, low production cost, reduced environmental impact, and compatibility with biomedical applications. In this work, manganese nanoparticles (Mn NPs) were produced through a plant-mediated approach in which the plant extract functioned simultaneously as a reducing and capping agent. The synthesis was carried out under gentle reaction conditions without relying on hazardous reagents or energy-intensive procedures, emphasizing the green and sustainable character of the method. The resulting Mn NPs were thoroughly characterized using a range of analytical techniques that verified their successful formation, nanoscale dimensions, homogeneous morphology, and satisfactory colloidal stability. Their antibacterial performance was subsequently evaluated against selected Gram-positive and Gram-negative bacterial strains. The Mn NPs demonstrated strong antimicrobial activity by generating distinct inhibition zones against all tested bacteria. Among the bacterial isolates,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.